Search
for

    Glossary Cialis

    medication used to treat erectile dysfunction and benign prostatic hyperplasia

    Cialis, also known by its generic name Tadalafil, is a medication primarily used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It works by increasing blood flow to particular areas of the body, including the penis, which helps achieve and maintain an erection. Additionally, it can be used to treat pulmonary arterial hypertension by relaxing blood vessels in the lungs to allow blood to flow more easily.

    Related Terms

    Sort by

    Research 30 of 464

    1. HİRSUTİZMLİ TÜRK KADINLARDA YAŞAM KALİTESİNİN DEĞERLENDİRİLMESİ: ÇAPRAZ KESİTSEL ÇALIŞMA Acta Medica Nicomedia · 2023
    2. Gelişmekte olan insan fetüslerinin ve yetişkinlerin derisinde EZH2 ekspresyonu: karşılaştırmalı bir çalışma 2023
    3. Bakteriyel Selüloz Tabanlı Hidrojel Taşıyıcı ile Topikal Uygulanan Tideglusib’in Sıçanlarda Oluşturulan Palatinal Yaranın İyileşmesi Üzerine Etkisinin Makroskobik Değerlendirmesi: Bir Öncül Çalışma European Journal of Research in Dentistry · 2023 · 1 citations
    4. By the way, doctor. Finasteride has been prescribed for my BPH. I think that the most frequent side effect is erectile dysfunction or loss of sexual desire. Would Levita or a similar drug (like Viagra or Cialis) overcome the side effects of finasteride? PubMed · 2009 · 2 citations
    5. Organic Causes of Erectile Dysfunction in Men Under 40 Urologia Internationalis · 2013 · 2152 citations
    6. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    7. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    8. Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia Therapeutic advances in urology · 2016 · 14 citations
    9. Selective and rapid determination of tadalafil and finasteride using solid phase extraction by high performance liquid chromatography and tandem mass spectrometry Journal of Pharmaceutical and Biomedical Analysis · 2018 · 9 citations
    10. 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study The Journal of Urology · 2004 · 8 citations
    11. The Osler Lecture 2012 'Pharmacology 2.0, medicines, drugs and human enhancement' QJM: An International Journal of Medicine · 2012 · 5 citations
    12. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    13. Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules BMC chemistry · 2022 · 3 citations
    14. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    15. Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men Current Geriatrics Reports · 2019 · 2 citations
    16. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    17. Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride Journal of personalized medicine · 2023 · 1 citations
    18. 311 Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia The Journal of Sexual Medicine · 2018 · 1 citations
    19. Approaching Erectile Dysfunction in Dermatology Patients JAMA Dermatology · 2013 · 1 citations
    20. Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance Molecular Pharmaceutics · 2025
    21. Drug–DrugCoamorphous System of Tadalafil andFinasteride for Enhanced Pharmaceutical Performance OPAL (Open@LaTrobe) (La Trobe University) · 2025
    22. Trimodal mini-invasive therapy for stable-phase Peyronie's disease: a two-center real-life prospective pilot study 2025
    23. RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation International Journal of Drug Delivery Technology · 2025
    24. BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FINASTERIDE, TADALAFIL, AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RAT PLASMA BY USING LC-MS/MS International Journal of Applied Pharmaceutics · 2024
    25. Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries Urology · 2024
    26. Logic-Based Modeling and Drug Repurposing for the Prediction of Novel Therapeutic Targets and Combination Regimens against E2F1-Driven Melanoma Progression 2023
    27. Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2023
    28. PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS? 2022
    29. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    30. PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION The Journal of Urology · 2018